Tisagenlecleucel Cell Dispersion

Medicine Status PIL SPC XPIL EDM - Patient EDM - HCP Legal Category Active Ingredient(s) Company Kymriah 1.2 x 106 – 6 x 108 cells dispersion for infusion
No Recent Update
PIL 16/04/20 SPC 24/06/21 No--A Novartis Ireland Limited